Acorah Software Products - Accounts Production 16.4.675 false true true 31 March 2023 1 January 2023 false 1 April 2023 31 March 2024 31 March 2024 13814119 W & S RED ROSE HEALTHCARE LIMITED Mr MOHAMMED SHABIR iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13814119 2023-03-31 13814119 2024-03-31 13814119 2023-04-01 2024-03-31 13814119 frs-core:CurrentFinancialInstruments 2024-03-31 13814119 frs-core:Non-currentFinancialInstruments 2024-03-31 13814119 frs-core:ShareCapital 2024-03-31 13814119 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 13814119 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13814119 frs-bus:FilletedAccounts 2023-04-01 2024-03-31 13814119 frs-bus:SmallEntities 2023-04-01 2024-03-31 13814119 frs-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 13814119 frs-bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 13814119 frs-core:CostValuation 2023-03-31 13814119 frs-core:CostValuation 2024-03-31 13814119 frs-core:ProvisionsForImpairmentInvestments 2023-03-31 13814119 frs-core:ProvisionsForImpairmentInvestments 2024-03-31 13814119 frs-bus:Director1 2023-04-01 2024-03-31 13814119 frs-bus:Director2 2023-04-01 2024-03-31 13814119 frs-countries:EnglandWales 2023-04-01 2024-03-31 13814119 2022-12-31 13814119 2023-03-31 13814119 2023-01-01 2023-03-31 13814119 frs-core:CurrentFinancialInstruments 2023-03-31 13814119 frs-core:Non-currentFinancialInstruments 2023-03-31 13814119 frs-core:ShareCapital 2023-03-31 13814119 frs-core:RetainedEarningsAccumulatedLosses 2023-03-31
Registered number: 13814119
S & B DENTAL LIMITED
Unaudited Financial Statements
For The Year Ended 31 March 2024
DAVID LACEY & CO
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 13814119
31 March 2024 31 March 2023
Notes £ £ £ £
FIXED ASSETS
Investments 4 1,200,000 1,200,000
1,200,000 1,200,000
CURRENT ASSETS
Debtors 5 307 307
Cash at bank and in hand 1,189 1,354
1,496 1,661
Creditors: Amounts Falling Due Within One Year 6 (404,637 ) (402,277 )
NET CURRENT ASSETS (LIABILITIES) (403,141 ) (400,616 )
TOTAL ASSETS LESS CURRENT LIABILITIES 796,859 799,384
Creditors: Amounts Falling Due After More Than One Year 7 (820,773 ) (857,951 )
NET LIABILITIES (23,914 ) (58,567 )
CAPITAL AND RESERVES
Called up share capital 8 30 30
Profit and Loss Account (23,944 ) (58,597 )
SHAREHOLDERS' FUNDS (23,914) (58,567)
Page 1
Page 2
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
W & S RED ROSE HEALTHCARE LIMITED
Director
Mr MOHAMMED SHABIR
Director
25/09/2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
S & B DENTAL LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 13814119 . The registered office is SUITE 3, CASTLEGATE HOUSE, CASTLEGATE, YORK, YO19 5LP.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern. The directors have confirmed that they will support the Company for a period of not less than twelve months from the date of signing the balance sheet.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 2)
2 2
4. Investments
Subsidiaries
£
Cost
As at 1 April 2023 1,200,000
As at 31 March 2024 1,200,000
Provision
As at 1 April 2023 -
As at 31 March 2024 -
Net Book Value
As at 31 March 2024 1,200,000
As at 1 April 2023 1,200,000
5. Debtors
31 March 2024 31 March 2023
£ £
Due within one year
Other debtors 307 307
6. Creditors: Amounts Falling Due Within One Year
31 March 2024 31 March 2023
£ £
Bank loans and overdrafts 40,661 38,371
Other creditors 363,976 363,906
404,637 402,277
Page 3
Page 4
7. Creditors: Amounts Falling Due After More Than One Year
31 March 2024 31 March 2023
£ £
Bank loans 820,773 857,951
8. Share Capital
31 March 2024 31 March 2023
£ £
Allotted, Called up and fully paid 30 30
Page 4